《Cell,12月9日,Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-12-23
  • Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks
    William M. Schneider 5
    Joseph M. Luna 5
    H.-Heinrich Hoffmann 5
    Margaret R. MacDonald
    Charles M. Rice
    John T. Poirier 7
    Show all authors
    Show footnotes
    Published:December 09, 2020DOI:https://doi.org/10.1016/j.cell.2020.12.006

    Summary
    The COVID-19 pandemic has claimed the lives of over one million people worldwide. The causative agent, SARS-CoV-2, is a member of the Coronaviridae family of viruses that can cause respiratory infections of varying severity. The cellular host factors and pathways co-opted during SARS-CoV-2 and related coronavirus life cycles remain ill-defined. To address this gap, we performed genome-scale CRISPR knockout screens during infection by SARS-CoV-2 and three seasonal coronaviruses (HCoV-OC43, HCoV-NL63, and HCoV-229E). These screens uncovered host factors and pathways with pan-coronavirus and virus-specific functional roles, including major dependency on glycosaminoglycan biosynthesis, SREBP signaling, BMP signaling, and glycosylphosphatidylinositol biosynthesis, as well as a requirement for several poorly characterized proteins. We identified an absolute requirement for the VTT-domain containing protein TMEM41B for infection by SARS-CoV-2 and three seasonal coronaviruses. This human Coronaviridae host factor compendium represents a rich resource to develop new therapeutic strategies for acute COVID-19 and potential future coronavirus pandemics.

  • 原文来源:https://www.cell.com/cell/fulltext/S0092-8674(20)31676-7#%20
相关报告
  • 《Cell,10月24日,Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-11-17
    • Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells Zharko Daniloski 7 Tristan X. Jordan 7 Hans-Hermann Wessels Tuuli Lappalainen Benjamin R. tenOever Neville E. Sanjana 8 Published:October 24, 2020DOI:https://doi.org/10.1016/j.cell.2020.10.030 Summary To better understand host-virus genetic dependencies and find potential therapeutic targets for COVID-19, we performed a genome-scale CRISPR loss-of-function screen to identify host factors required for SARS-CoV-2 viral infection of human alveolar epithelial cells. Top-ranked genes cluster into distinct pathways, including the vacuolar ATPase proton pump, Retromer, and Commander complexes. We validate these gene targets using several orthogonal methods such as CRISPR knockout, RNA interference knockdown, and small-molecule inhibitors. Using single-cell RNA-sequencing, we identify shared transcriptional changes in cholesterol biosynthesis upon loss of top-ranked genes. In addition, given the key role of the ACE2 receptor in the early stages of viral entry, we show that loss of RAB7A reduces viral entry by sequestering the ACE2 receptor inside cells. Overall, this work provides a genome-scale, quantitative resource of the impact of the loss of each host gene on fitness/response to viral infection.
  • 《Cell,10月20日,Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-11-16
    • Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection Jin Wei Mia Madel Alfajaro Peter C. DeWeirdt Qin Yan John G. Doench Craig B. Wilen 18 Show all authors Show footnotes Published:October 20, 2020DOI:https://doi.org/10.1016/j.cell.2020.10.028 Summary Identification of host genes essential for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may reveal novel therapeutic targets and inform our understanding of coronavirus disease 2019 (COVID-19) pathogenesis. Here we performed genome-wide CRISPR screens in Vero-E6 cells with SARS-CoV-2, Middle East respiratory syndrome CoV (MERS-CoV), bat CoV HKU5 expressing the SARS-CoV-1 spike, and vesicular stomatitis virus (VSV) expressing the SARS-CoV-2 spike. We identified known SARS-CoV-2 host factors, including the receptor ACE2 and protease Cathepsin L. We additionally discovered pro-viral genes and pathways, including HMGB1 and the SWI/SNF chromatin remodeling complex, that are SARS lineage and pan-coronavirus specific, respectively. We show that HMGB1 regulates ACE2 expression and is critical for entry of SARS-CoV-2, SARS-CoV-1, and NL63. We also show that small-molecule antagonists of identified gene products inhibited SARS-CoV-2 infection in monkey and human cells, demonstrating the conserved role of these genetic hits across species. This identifies potential therapeutic targets for SARS-CoV-2 and reveals SARS lineage-specific and pan-CoV host factors that regulate susceptibility to highly pathogenic CoVs.